ORCID Profile
0000-0002-2971-0554
Current Organisations
Pacific Northwest National Laboratory
,
Washington State University
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Walter de Gruyter GmbH
Date: 12-09-2011
Abstract: The interactions of gold nanoparticles (AuNPs) with human serum albumin (HSA) greatly influence their in vivo characteristics. It is important to develop conjugates that can serve as ideal structural models to understand the interaction of AuNPs with HSA. We report the synthesis and stabilization of AuNPs in HSA matrix with no additional ligands on the surface of the NPs. The hydrodynamic size of the AuNP–HSA conjugate is 22 nm, and transmission electron microscopy (TEM) measurement shows the core size as 8–13 nm. We have performed strip assay to establish that the biological activity of HSA is retained even after conjugation. Our cellular toxicity evaluation studies show that AuNP–HSA conjugates are nontoxic and biocompatible.
Publisher: Wiley
Date: 09-2008
Abstract: The present study demonstrates an unprecedented green process for the production of gold nanoparticles by simple treatment of gold salts with soybean extracts. Reduction capabilities of antioxidant phytochemicals present in soybean and their ability to reduce gold salts chemically to nanoparticles with subsequent coating of proteins and a host of other phytochemicals present in soybean on the freshly generated gold nanoparticles are discussed. The new genre of green nanoparticles exhibit remarkable in vitro stability in various buffers including saline, histidine, HSA, and cysteine solutions. MTT assays reveal that the green gold nanoparticles are nontoxic and thus provide excellent opportunities for their applications in nanomedicine for molecular imaging and therapy. The overall strategy described herein for the generation of gold nanoparticles meets all 12 principles of green chemistry, as no "man-made" chemicals, other than the gold salts, are used in the green nanotechnological process.
Publisher: Royal Society of Chemistry (RSC)
Date: 2009
DOI: 10.1039/B822015H
Publisher: Proceedings of the National Academy of Sciences
Date: 16-07-2012
Abstract: Systemic delivery of therapeutic agents to solid tumors is hindered by vascular and interstitial barriers. We hypothesized that prostate tumor specific epigallocatechin-gallate (EGCg) functionalized radioactive gold nanoparticles, when delivered intratumorally (IT), would circumvent transport barriers, resulting in targeted delivery of therapeutic payloads. The results described herein support our hypothesis. We report the development of inherently therapeutic gold nanoparticles derived from the Au-198 isotope the range of the 198 Au β-particle (approximately 11 mm in tissue or approximately 1100 cell diameters) is sufficiently long to provide cross-fire effects of a radiation dose delivered to cells within the prostate gland and short enough to minimize the radiation dose to critical tissues near the periphery of the capsule. The formulation of biocompatible 198 AuNPs utilizes the redox chemistry of prostate tumor specific phytochemical EGCg as it converts gold salt into gold nanoparticles and also selectively binds with excellent affinity to Laminin67R receptors, which are over expressed in prostate tumor cells. Pharmacokinetic studies in PC-3 xenograft SCID mice showed approximately 72% retention of 198 AuNP-EGCg in tumors 24 h after intratumoral administration. Therapeutic studies showed 80% reduction of tumor volumes after 28 d demonstrating significant inhibition of tumor growth compared to controls. This innovative nanotechnological approach serves as a basis for designing biocompatible target specific antineoplastic agents. This novel intratumorally injectable 198 AuNP-EGCg nanotherapeutic agent may provide significant advances in oncology for use as an effective treatment for prostate and other solid tumors.
Location: United States of America
No related grants have been discovered for Satish Nune.